JP2024519943A5 - - Google Patents

Info

Publication number
JP2024519943A5
JP2024519943A5 JP2023572071A JP2023572071A JP2024519943A5 JP 2024519943 A5 JP2024519943 A5 JP 2024519943A5 JP 2023572071 A JP2023572071 A JP 2023572071A JP 2023572071 A JP2023572071 A JP 2023572071A JP 2024519943 A5 JP2024519943 A5 JP 2024519943A5
Authority
JP
Japan
Prior art keywords
amino acid
seq
acid sequence
baff
domain
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Pending
Application number
JP2023572071A
Other languages
English (en)
Japanese (ja)
Other versions
JP2024519943A (ja
Filing date
Publication date
Application filed filed Critical
Priority claimed from PCT/CN2022/093782 external-priority patent/WO2022242710A1/zh
Publication of JP2024519943A publication Critical patent/JP2024519943A/ja
Publication of JP2024519943A5 publication Critical patent/JP2024519943A5/ja
Pending legal-status Critical Current

Links

JP2023572071A 2021-05-19 2022-05-19 Baff-rを特異的に認識するキメラ抗原受容体分子及びその使用 Pending JP2024519943A (ja)

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
CNPCT/CN2021/094605 2021-05-19
CN2021094605 2021-05-19
PCT/CN2022/093782 WO2022242710A1 (zh) 2021-05-19 2022-05-19 一种特异性识别baff-r的嵌合抗原受体分子及其应用

Publications (2)

Publication Number Publication Date
JP2024519943A JP2024519943A (ja) 2024-05-21
JP2024519943A5 true JP2024519943A5 (https=) 2024-09-05

Family

ID=84060535

Family Applications (1)

Application Number Title Priority Date Filing Date
JP2023572071A Pending JP2024519943A (ja) 2021-05-19 2022-05-19 Baff-rを特異的に認識するキメラ抗原受容体分子及びその使用

Country Status (6)

Country Link
US (1) US20250268939A1 (https=)
EP (1) EP4342913B1 (https=)
JP (1) JP2024519943A (https=)
CN (1) CN115368473A (https=)
TW (1) TW202300520A (https=)
WO (1) WO2022242710A1 (https=)

Families Citing this family (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
WO2025067496A1 (zh) * 2023-09-28 2025-04-03 南京驯鹿生物技术股份有限公司 靶向baff-r的全人源抗体、car-t细胞及其应用
CN119241730B (zh) * 2024-12-09 2025-03-04 天津医科大学总医院空港医院 一种分泌il10靶向baffr嵌合抗原受体、car-t细胞和应用

Family Cites Families (9)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
DE3920358A1 (de) 1989-06-22 1991-01-17 Behringwerke Ag Bispezifische und oligospezifische, mono- und oligovalente antikoerperkonstrukte, ihre herstellung und verwendung
ATE207080T1 (de) 1991-11-25 2001-11-15 Enzon Inc Multivalente antigen-bindende proteine
US5641870A (en) 1995-04-20 1997-06-24 Genentech, Inc. Low pH hydrophobic interaction chromatography for antibody purification
CN101851291B (zh) * 2010-02-09 2011-10-26 中国人民解放军第四军医大学 一种抗人baff单克隆抗体的重链和轻链可变区
HK1255161A1 (zh) * 2015-07-15 2019-08-09 Juno Therapeutics, Inc. 用於过继性细胞治疗的工程细胞
EP4628094A3 (en) * 2016-06-06 2025-12-31 City of Hope BAFF-R ANTIBODIES AND THEIR USES
IL308798A (en) * 2016-06-06 2024-01-01 Univ Texas Baff-r targeted chimeric antigen receptor-modified t-cells and uses thereof
EP3755347B1 (en) * 2018-02-21 2025-06-25 Board of Regents, The University of Texas System Universal antigen presenting cells and uses thereof
WO2021163989A1 (en) 2020-02-21 2021-08-26 Yinnuolai Biotech Ltd. Anti-baff receptor antibodies and uses thereof

Similar Documents

Publication Publication Date Title
JP2025032091A5 (https=)
JP2021087455A5 (https=)
JP2022523781A5 (https=)
JP2017524367A5 (https=)
JP2021094037A5 (https=)
RU2017105160A (ru) Лечение рака с помощью химерного антигенного рецептора к cd33
JP2019523301A5 (https=)
HRP20221348T1 (hr) Kimerni receptori i postupci njihove uporabe
JP2017522880A5 (https=)
HRP20251135T1 (hr) Postupci dobivanja kimernih stanica koje eksprimiraju antigenske receptore
JP2021530233A5 (https=)
RU2019128921A (ru) Антитело к il-13ra2 и его применение
RU2017105161A (ru) Лечение рака с использованием химерного антигенного рецептора cll-1
JP2019516352A5 (https=)
KR20210053318A (ko) 항-메소텔린 키메라 항원 수용체(car) 작제물 및 이의 용도
RU2017105065A (ru) Лечение злокачественного новообразования с использованием гуманизированного химерного антигенного рецептора против всма
JP2017522879A5 (https=)
JP2018527014A5 (https=)
JP2020506700A5 (https=)
JP2018538339A5 (https=)
JP2022542543A5 (https=)
JP2017530694A5 (https=)
CA3180321A1 (en) Multifunctional molecules that bind to t cell related cancer cells and uses thereof
JP2024519943A5 (https=)
JP2017527271A5 (https=)